90+ peptides. One quality system.

CAS: 2023788-19-2
Vial: 2 mg–120 mg

Retatrutide

GIP / GLP-1 / glucagon tri-agonist

CAS: 2381089-83-2
Vial: 5 mg–60 mg

Semaglutide

GLP-1 receptor agonist

CAS: 910463-68-2
Vial: 2 mg–50 mg

Cagrilintide

Long-acting amylin analog

CAS: 1415456-99-3
Vial: 2 mg–10 mg

BPC-157

Body Protection Compound 15-mer

CAS: 137525-51-0
Vial: 2 mg–10 mg

TB-500

Thymosin β4 fragment

CAS: 885340-08-9
Vial: 2 mg–10 mg

Wolverine Blend

BPC-157 + TB-500 repair-stack blend

≥99.0% per component

CAS: (blend — components have individual CAS)
Vial: 10 mg–80 mg

GHK-Cu

Copper tripeptide-1

CAS: 89030-95-5
Vial: 50 mg · 100 mg

Epitalon

Pineal gland tetrapeptide

CAS: 307297-39-8
Vial: 10 mg · 50 mg

MOTS-c

Mitochondrial-derived peptide

CAS: 1627580-64-6
Vial: 10 mg–40 mg

SS-31 (Elamipretide)

Mitochondrial-targeted peptide

CAS: 736992-21-5
Vial: 5 mg–50 mg

Semax

ACTH 4-10 analog · cognitive research peptide

CAS: 80714-61-0
Vial: 2 mg–15 mg

Selank

Tuftsin analog · anxiolytic research peptide

CAS: 129954-34-3
Vial: 5 mg · 10 mg

DSIP

Delta sleep-inducing peptide

CAS: 62568-57-4
Vial: 2 mg–15 mg

Snap-8

Acetyl octapeptide-3 · cosmetic peptide

CAS: 868844-74-0
Vial: 10 mg · 100 mg

Matrixyl

Palmitoyl pentapeptide-4

CAS: 214047-00-4
Vial: 10 mg

AHK-Cu

Copper peptide AHK

CAS: (complex — confirm with QA)
Vial: 20 mg · 50 mg

KPV

Lys-Pro-Val α-MSH C-terminal tripeptide

CAS: 67727-97-3
Vial: 5 mg · 10 mg

LL-37

Cathelicidin antimicrobial peptide

CAS: 154947-66-7
Vial: 5 mg

CJC-1295 + Ipamorelin

GH-axis blend (CJC-1295 no DAC + Ipamorelin)

≥99.0% per component

CAS: (blend)
Vial: 10 mg (5+5)

CJC-1295 (no DAC)

Modified GRF 1-29 · GHRH analog

CAS: (see DAC-version distinction)
Vial: 2 mg–10 mg

Ipamorelin

Ghrelin / GHSR pathway GH-release peptide

CAS: 170851-70-4
Vial: 2 mg–10 mg

Sermorelin

GHRH 1-29 fragment

CAS: 86168-78-7
Vial: 2 mg–10 mg

NAD+

Nicotinamide adenine dinucleotide

CAS: 53-84-9
Vial: 100 mg–1000 mg

AOD9604

Modified HGH fragment 176–191 (anti-obesity drug candidate)

CAS: 221231-10-3
Vial: 2 mg–10 mg

HGH Fragment 176-191

C-terminal fragment of human growth hormone (176–191)

CAS: 66004-57-7
Vial: 1 mg–15 mg

Tesamorelin + Ipamorelin Blend (15 mg)

GH-axis blend (Tesamorelin + Ipamorelin) — 15 mg total

CAS: (blend — components have individual CAS numbers)
Vial: 15 mg

CJC-1295 with DAC

Long-acting GHRH analog with Drug Affinity Complex

CAS: 863288-34-0
Vial: 2 mg · 5 mg

GHRP-2

Growth-hormone-releasing peptide-2 · Pralmorelin

CAS: 158861-67-7
Vial: 5 mg · 10 mg

GHRP-6

Growth-hormone-releasing peptide-6

CAS: 87616-84-0
Vial: 5 mg · 10 mg

Tesamorelin

GHRH analog · approved for HIV-associated lipodystrophy

CAS: 218949-48-5
Vial: 2 mg–20 mg

GLP1-R-30 (Supplier Code)

Supplier reference code (suspected Retatrutide class) · 30 mg

CAS: (supplier code — confirm API via COA)
Vial: 30 mg

GLP1-R-5 (Supplier Code)

Supplier reference code (suspected Retatrutide class) · 5 mg

CAS: (supplier code — confirm API via COA)
Vial: 5 mg

GLP1-S-30 (Supplier Code)

Supplier reference code (suspected Semaglutide class) · 30 mg

CAS: (supplier code — confirm API via COA)
Vial: 30 mg

GLP1-T-10 (Supplier Code)

Supplier reference code (suspected Tirzepatide class) · 10 mg

CAS: (supplier code — confirm API via COA)
Vial: 10 mg

GLP1-T-30 (Supplier Code)

Supplier reference code (suspected Tirzepatide class) · 30 mg

CAS: (supplier code — confirm API via COA)
Vial: 30 mg

GLP1-T-60 (Supplier Code)

Supplier reference code (suspected Tirzepatide class) · 60 mg

CAS: (supplier code — confirm API via COA)
Vial: 60 mg

Liraglutide

GLP-1 receptor agonist (long-acting)

CAS: 204656-20-2
Vial: 5 mg–30 mg

Mazdutide

GLP-1 / glucagon dual receptor agonist (IBI362 / LY3305677)

CAS: 2252403-56-6
Vial: 10 mg

Survodutide

GLP-1 / glucagon dual receptor agonist (BI 456906)

CAS: 2365457-03-9
Vial: 10 mg

PEG-MGF

PEGylated Mechano Growth Factor

CAS: 108174-48-7 (verification pending — please confirm via COA)
Vial: 2 mg–10 mg

5-Amino-1MQ

NNMT inhibitor (5-Amino-1-methylquinolinium iodide)

CAS: 42464-96-0
Vial: 5 mg–50 mg

AICAR (Acadesine)

AMPK pathway activator · exercise mimetic research compound

CAS: 2627-69-2
Vial: 50 mg · 100 mg

L-Carnitine

Fatty-acid-transport nutrient

CAS: 541-15-1
Vial: 2 mg–1200 mg (solution)

SLU-PP-332

Pan-ERR agonist · exercise mimetic compound

CAS: 303760-60-3
Vial: 5 mg · 10 mg

Thymalin / Thymulin

Thymic immune-modulation peptide(s)

CAS: 63958-90-7 (Thymulin) / Thymalin extract — confirm via COA
Vial: 10 mg

Thymosin Alpha-1 (Thymalfasin)

28-amino-acid thymic immune-modulation peptide

CAS: 62304-98-7
Vial: 5 mg · 10 mg

ADMAX (Supplier Trade Name)

Supplier trade-name product · API to be confirmed

CAS: (supplier code — confirm via COA)
Vial: 5 mg · 10 mg

Klow (Supplier Trade Name)

Supplier trade-name product · API to be confirmed

CAS: (supplier code — confirm via COA)
Vial: 5 mg–80 mg

PROSTAMAX (Supplier Trade Name)

Supplier trade-name product · API to be confirmed

CAS: (supplier code — confirm via COA)
Vial: 20 mg

Cerebrolysin

Neurotrophic peptide / protein-hydrolysate complex

CAS: (complex peptide mixture — no single CAS)
Vial: 60 mg

CagriSema

Cagrilintide + Semaglutide combination

CAS: (blend — components have individual CAS numbers)
Vial: 5 mg–20 mg

GLOW Blend

Beauty / repair multi-peptide blend (commonly GHK-Cu + BPC-157 + TB-500)

CAS: (blend — components have individual CAS numbers)
Vial: 70 mg

Lemon Bottle

Supplier-branded aesthetic / lipolytic solution

CAS: (blend — components have individual CAS numbers)
Vial: 10 ml

Lipo-C (MIC + B-vitamin blend)

Methionine / Inositol / Choline + B-vitamin lipotropic blend

CAS: (blend — components have individual CAS numbers)
Vial: 10 mg · 10 ml

Melatonin

Pineal hormone · sleep / circadian-rhythm research compound

CAS: 73-31-4
Vial: 10 mg

Glutathione (GSH)

Reduced glutathione · tripeptide antioxidant

CAS: 70-18-8
Vial: 400 mg–1500 mg

Botulinum Toxin Type A

Type A neurotoxin · heavily regulated biological

CAS: 93384-43-1
Vial: 100 IU

HCG (Human Chorionic Gonadotropin)

Gonadotropin glycoprotein hormone · heavily regulated

CAS: 9002-61-3
Vial: 1000 IU–10 mg

HMG (Human Menopausal Gonadotropin / Menotropins)

FSH / LH-active gonadotropin · heavily regulated

CAS: 9002-68-0
Vial: 75 IU

IGF-1 LR3

Long-Arg3 IGF-1 (long-acting IGF-1 analog)

CAS: 946870-92-4
Vial: 100 mcg–2 mg

MGF (Mechano Growth Factor)

IGF-1 Ec splice-variant peptide

CAS: (verification pending — please confirm via COA)
Vial: 2 mg

Bronchogen

Khavinson bioregulator tetrapeptide (Ala-Glu-Asp-Leu, AEDL)

CAS: (verification pending — please confirm via COA)
Vial: 20 mg

Cardiogen

Khavinson cardiovascular short-peptide bioregulator

CAS: (verification pending — please confirm via COA)
Vial: 20 mg

Cartalax

Khavinson cartilage / connective-tissue bioregulator

CAS: (verification pending — please confirm via COA)
Vial: 20 mg

Cortagen

Khavinson cortical bioregulator tetrapeptide (Ala-Glu-Asp-Pro, AEDP)

CAS: (verification pending — please confirm via COA)
Vial: 20 mg

Crystagen

Khavinson immune / endocrine short-peptide bioregulator

CAS: (verification pending — please confirm via COA)
Vial: 20 mg

Pinealon

Khavinson neuroprotective tripeptide (Glu-Asp-Arg, EDR)

CAS: 175175-23-2
Vial: 5 mg–20 mg

Vesugen

Khavinson vascular tripeptide (Lys-Glu-Asp, KED)

CAS: (verification pending — please confirm via COA)
Vial: 10 mg

Adipotide (FTPP)

Prohibitin-targeting adipose vascular peptide

CAS: (verification pending — please confirm via COA)
Vial: 2 mg–10 mg

B7-33

Single-chain relaxin analog · RXFP1 agonist

CAS: 1818415-56-3
Vial: 2 mg · 10 mg

PNC-27

p53-HDM2-binding · penetratin-fused research peptide

CAS: (verification pending — please confirm via COA)
Vial: 10 mg

Kisspeptin-10

Metastin (45-54) · HPG-axis research peptide

CAS: 374675-21-5
Vial: 5 mg · 10 mg

P21 (P021)

CNTF-derived neurogenic tetrapeptide with adamantane moiety

CAS: (verification pending — please confirm via COA)
Vial: 5 mg

VIP (Vasoactive Intestinal Peptide)

28-residue vasoactive / immune neuropeptide

CAS: 40077-57-4
Vial: 10 mg

Oxytocin

Posterior-pituitary neuropeptide hormone · regulated

CAS: 50-56-6
Vial: 2 mg–10 mg

ARA-290 (Cibinetide)

EPO-derived 11-mer · cytoprotective research peptide

CAS: 1208243-50-8
Vial: 10 mg · 16 mg

FOXO4-DRI (FOX-04)

D-retro-inverso FOXO4 / p53 interaction blocker · senolytic peptide

CAS: 2460055-10-9
Vial: 2 mg · 10 mg

B-12 (Vitamin B12 · Cyanocobalamin / Methylcobalamin)

Cyanocobalamin (68-19-9) or Methylcobalamin (13422-55-4) form

CAS: 68-19-9 (Cyanocobalamin) / 13422-55-4 (Methylcobalamin)
Vial: 1 mg/ml · 10 mg

EPO (Erythropoietin)

Recombinant erythropoietin protein · heavily regulated

CAS: 11096-26-7
Vial: 3000 IU

HGH (Somatropin · Human Growth Hormone)

Recombinant human growth hormone · heavily regulated biological

CAS: 12629-01-5
Vial: 6 IU–40 IU

ACE-031 (ActRIIB-Fc Fusion)

ActRIIB-Fc decoy receptor fusion protein · myostatin pathway

CAS: (fusion protein — no single CAS; confirm via COA)
Vial: 1 mg

0.6% Acetic Acid Water

0.6% acetic-acid reconstitution diluent

CAS: (blend — components: acetic acid 64-19-7, water 7732-18-5)
Vial: 3 ml

BAC Water (Bacteriostatic Water for Injection)

0.9% benzyl-alcohol bacteriostatic water

CAS: (blend — components: benzyl alcohol 100-51-6, water 7732-18-5)
Vial: 3 ml · 10 ml

Saline (0.9% Sodium Chloride Injection)

0.9% isotonic sodium-chloride reconstitution diluent

CAS: (blend — components: sodium chloride 7647-14-5, water 7732-18-5)
Vial: 3 ml · 10 ml

Sterile Water for Injection

Preservative-free sterile water reconstitution diluent

CAS: 7732-18-5
Vial: 3 ml · 10 ml

Acetic Acid (Glacial / Concentrated Solvent)

Acidification solvent · process auxiliary

CAS: 64-19-7
Vial: 10 ml

Melanotan II (MT-II)

Melanocortin receptor agonist · regulated research peptide

CAS: 121062-08-6
Vial: 10 mg

Melanotan I (Afamelanotide)

α-MSH analog · approved for erythropoietic protoporphyria

CAS: 75921-69-6
Vial: 10 mg

PT-141 (Bremelanotide)

Melanocortin-4 receptor agonist · approved for HSDD

CAS: 189691-06-3
Vial: 10 mg